BFA
EW icon

Bill Few Associates’s Edwards Lifesciences EW Stock Holding History

Bill Few Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,628
Closed -$243K – 180
2024
Q2 		$243K Buy
2,628
+221
+9% +$19.6K 0.09% 149
2024
Q1 		$230K Buy
+2,407
New +$202K 0.09% 151
2023
Q4 		– Sell
-3,071
Closed -$213K – 157
2023
Q3 		$213K Hold
3,071
– – 0.11% 129
2023
Q2 		$290K Hold
3,071
– – 0.15% 112
2023
Q1 		$254K Hold
3,071
– – 0.14% 111
2022
Q4 		$229K Sell
3,071
-236
-7% -$18.2K 0.14% 112
2022
Q3 		$273K Sell
3,307
-111
-3% -$10.7K 0.18% 93
2022
Q2 		$325K Hold
3,418
– – 0.21% 84
2022
Q1 		$402K Buy
+3,418
New +$383K 0.22% 82

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bill Few Associates's EW Position: Q3 2024 in Review

Bill Few Associates sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 2,628 shares — an estimated $243K sold.

Bill Few Associates first reported a position in EW in Q1 2022 and held it in 9 quarters. The position peaked at $402K in Q1 2022. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Bill Few Associates reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Bill Few Associates sold 2,628 Edwards Lifesciences shares in Q3 2024, an estimated $243K.
  • Bill Few Associates first reported a position in Edwards Lifesciences in Q1 2022 and held it in 9 quarters.
  • Bill Few Associates's Edwards Lifesciences position peaked at $402K in Q1 2022.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Bill Few Associates's 13F filing for Q3 2024, filed 15 Oct 2024.